BioSpace News Archive

Innovation unlocks previously inaccessible cellular information and makes more experiments feasible in proteogenomics, immune monitoring, and single-cell genomics

Proof-of-concept study indicates utility of patient-derived cells for evaluating drug response

In 2017, funding for HIV prevention research and development (R&D) decreased by 3.5 percent (US$40 million) from the previous year, falling to US$1.13 billion.

The win in the patent litigation strengthen Orexo’s long term business opportunities

Nordic Nanovector ASA today announces that Betalutin® (177Lu-satetraxetan-lilotomab) has been granted a Promising Innovative Medicine (PIM) designation by the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) for the treatment of patients with advanced relapsed/refractory follicular lymphoma (R/R FL).

Calidi Biotherapeutics, Inc. today announced that it has been granted a new patent from the United States Patent Office (USPTO).

Mercaptor Discoveries announced today that Dr. Adriano Aguzzi, MD, PhD, is heading up the formation of its Scientific Advisory Board (SAB). D

Chairman & CEO Mark Alles of Celgene to deliver keynote speech at Washington State Life Science Summit

Quarterly net revenues of $64.8 million, representing 29 percent growth versus the third quarter 2017 and 5 percent growth versus the second quarter 2018

CTI BioPharma Corp. (CTI BioPharma) (NASDAQ: CTIC) today announced that management plans to report its third quarter 2018 financial results on Thursday, November 1, 2018,